An elderly woman looking off into the distance.
An elderly woman looking off into the distance.

Investor Relations

Investor Relations represents MorphoSys and its equity story to the financial market and supports the Company's overall strategic communication. Through active and transparent investor relations work, the aim is to enable investors to make an informed decision of the Company.

Corporate Presentations and Reports


Corporate Presentation

Overview of our business strategy, mid- to late-stage oncology pipeline, financials and investment thesis.  

AR DT with title
AR MB with title

Annual Report 2022

We offer insights into our company, our mission as well as our corporate and financial report, our clinical pipeline and much more.

NFR DT with title
NFR MB with title

Non-Financial Group Report 2022

We provide information on business ethics and compliance as well as social, employee and environmental issues.

Third Quarter 2023 Financial Results

Press Release
Press Release
Read Press Release
Presentation Icon
Presentation for webcast
pdf | 1.24 MB
Go to Webcast

Events & Conferences

05 Dec 2023

The JMP Securities Hematology and Oncology Summit (Virtual)

Our CEO, Jean-Paul Kress, M.D., will present the company during a Webcast.

Date: Tuesday, December 5
Time: 12.30pm ET

Access Webcast

11 Dec 2023

ASH 2023 Investor Event with Medical Experts

The event will highlight pelabresib’s potential in first-line myelofibrosis with a comprehensive overview of the Phase 3 MANIFEST-2 trial results, which will be presented during an oral presentation at ASH 2023 on Sunday December 10. There will be live presentations from and a Q&A opportunity with MorphoSys management and leading medical experts. 

Monday, December 11, 7:00 a.m. – 8:30 a.m. PST  (10:00 a.m. - 11:30 a.m. EST / 4:00 p.m. - 5:30 p.m. CET)

Webcast Presentation

10 Jan 2024

42nd Annual J.P. Morgan Healthcare Conference

Our CEO, Jean-Paul Kress, M.D., will present MorphoSys during a Webcast.

Date: Wednesday, January 10, 2024
Time: 3.00 - 3.40pm PST

Access Webcast


Financial Information

Financial Information

Take a closer look at our Financial Guidance 2023 and the Fundamentals of MorphoSys.

Annual General Meeting

The virtual Annual General Meeting 2023 of MorphoSys AG.


Stock Information

MorphoSys stock information in detail.

Corporate Governance

We believe that our commitment to high Corporate Governance standards will ultimately increase shareholder value.

clinical trials
Clinical trials

Our Understanding of Sustainability

We are conscious of the responsibility we share for present and future generations and see sustainable action as a prerequisite for long-term business success.

Investor Contact




Tel. +49 89 89927 179